T1	intervention 27 45	axillary clearance
T2	control 53 74	no axillary clearance
T4	outcome 1473 1483	6-year DFS
T5	iv-bin-percent 1485 1488	67%
T6	cv-bin-percent 1491 1494	66%
T9	eligibility 578 720	with clinically node-negative operable breast cancer in whom adjuvant tamoxifen was considered indicated regardless of pathologic nodal status
T10	outcome-Measure 913 915	QL
T11	total-participants 980 983	473
T12	intervention-participants 994 997	234
T13	control-participants 1010 1013	239
T14	age 1064 1072	74 years
T16	outcome 1571 1580	6-year OS
T17	iv-bin-percent 1582 1585	75%
T18	cv-bin-percent 1588 1591	73%
T3	outcome 1468 1471	DFS
T7	outcome 1567 1569	OS
